Offers a Clear Look at Corneal Crosslinking

March 14, 2012 (PRLEAP.COM) Health News has published a new article on corneal collagen crosslinking (CXL). The procedure is awaiting Food & Drug Administration approval for treatment of the cornea-thinning condition called keratoconus, as well as corneal weakness after LASIK.

The article, Corneal Crosslinking for Keratoconus and LASIK Complications, discusses the two main types of CXL, who are candidates for the procedure, and what to expect during and after CXL.

"In most cases, the corneal shape improves or remains stable following CXL, and patients with conditions such as keratoconus will have an improved ability to wear contact lenses," said William Trattler, MD, a Miami-based ophthalmologist and corneal crosslinking expert who reviewed the article.

The article also includes the story of Olympic bobsledder Steve Holcomb, who almost had to give up the sport because of his failing eyesight from keratoconus. After undergoing corneal crosslinking followed by implantation of a special contact lens (ICL), he and his team went on to win a gold medal in the 2010 Winter Olympics. The article includes information on the minimally invasive corneal crosslinking technique his eye surgeon, Dr. Brian Boxer Wachler, had developed and later renamed as "Holcomb C3-R" in Holcomb's honor.

The article is in the Conditions and Diseases section of, at

Online since 2000, is an independent resource providing consumers with hundreds of pages of trustworthy, up-to-date information on vision correction and eye health. The site is a National Gold Sponsor of Optometry Giving Sight and is certified by the Health on the Net Foundation. It is expected to serve more than 15 million unique visitors this year.